Resources

1^stBiennial Meeting of Asian Society of Gynecologic Oncology

Date : November 22, 2009
Venue : Toshi Center Hotel Room 701

Opening Address

Closing Address

Commemoration Lecture from IGCS and SGO

Commemoration Lecture from IGCS and SGO
Date and Time:	November 22nd (Sunday) 12:40~13:40
	Global cooperation in gynecologic cancer
Chair:	Shingo Fujii (National Hospital Organaization Kyoto Medical Center, Japan)
Speaker:	Edward L. Trimble (National Cancer Institute, USA)

Symposium on Cervical Cancer

Symposium on Cervical Cancer
Part 1 Epidemiology and Diagnosis
Date and Time:	November 22nd (Sunday) 9:00~10:40
Chairs:	Mohammad Farid Aziz (University of Indonesia, Indonesia) Ikuo Konishi (Kyoto University, Japan) 1. Risk factors of Gynecologic Cancer Woong Ju (Department of Obstetrics and Gynecology, School of Medicine, Ewha Womans University, Seoul, Korea) 2. Epidemiology and Screening of Cervical Cancer in Hong Kong Annie NY Cheung (Department of Pathology and Department of Obstetrics and Gynaecology, The University of Hong Kong, Hong Kong) 3. Prognostic significance of Serum Vascular Endothelial Growth Factor C (Serum VEGF C) and Lymph Vascular Space Invasion in Early Stage Cervical Cancer Heru Priyanto Samadi (Oncology Division Department of Obstetrics and Gynecology. Dr. Moewardi Hospital Faculty of Medicine Sebelas Maret Univeristy . Solo. Centre Java. Indonesia) 4. Tumor Necrosis Factor alpha Promoter Polymorphisms in Neuroendocrine Adenocarcinoma of the Uterine Cervix Chih Long Chang (Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei Taiwan)
Part 2 HPV Vaccine and Prevention sponsored by Glaxo Smith Kline
Date and Time:	November 22nd (Sunday) 10:40~12:00
Chairs:	Hee Sug Ryu (Ajou University, Korea) Hiroyuki Yoshikawa (University of Tsukuda, Japan) 1. Current status of HPV infection and vaccination in Korea Hyun Hoon Chung (Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea) 2. Efficacy, Immunogenicity and Safety of HPV 16/18 AS04 Adjuvanted Vaccine and Evaluation of Cost Effectiveness in Japan Ryo Konno (Department of Obstetrics and Gynecology, Jichi Medical University, Saitama Medical Center, Saitama, Japan) 3. Celecoxib as a future chemoprevention agent by reduces proliferation, increases apoptosis and tumor size reduction through Cox 2 PGE2 pathway activity Supriadi Gandamihardja (University of Padjadjaran, Bandung, Indonesia)
Part 3 New Trend of Treatment
Date and Time:	November 22nd (Sunday) 15:10~17:30
Chairs:	Sarikapan Wilailak (Ramathibodi Hospital, Mahidol University, Thailand) Satoru Sagae (JR Sapporo Hospital, Japan) 1. Laparoscopic management of cervical cancer Joo Hyun Nam (Department of Obstetrics and Gynecology, College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea) 2. Laparoscopic Extraperitoneal Para aortic Lymph Node Dissection in Gynecologic Cancers Kung Liahng Wang (Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan) 3. Abdominal radical trachelectomy for invasive cervical cancer patients who desire preserving fertility Hiroaki Kobayashi (Dept. of Gynecology and Obstetrics, Graduate School of Medical Scineces, Kyushu University, Fukuoka, Japan) 4. Evolving Radiotherapy in Cervical Cancer; from 2D to 4D IGRT Chomporn Sitathanee (Radiation Oncology Division, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand) 5. Are we justified for concomitant chemo radiation in Advanced Stage Cancer Cervix? Shyam Kishore Shrivastava (Department of Radiation Oncology, Tata Memorial Hospital, Parel, Mumbai, India) 6. New Trends of Treatment for Cervical Cancer: The Singapore Experience: the use of the GOG score to tailor postop management for early stage cervical cancer Chia Yin Nin (Department of Gynaecologic Oncology, KK Women's and Children's Hospital, Singapore)